ClassID:

96436

C07H19/207 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide

Recent Application in this class:
#1
20260152638
2026-06-04

PROTECTED DYE-LABELED REAGENTS

#2
20260146059
2026-05-28

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

#3
20260115216
2026-04-30

NUCLEIC ACID PRECURSOR

#4
20260109726
2026-04-23

Immobilized 4,5-Dicyanoimidazole, and Preparation Method and Application Thereof

#5
20250319113
2025-10-16

INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE

#6
20250243235
2025-07-31

Beta-D-2'-DEOXY-2'-alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6- SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT

#7
20250188534
2025-06-12

MODIFIED NUCLEOTIDE REAGENTS

#8
20250171487
2025-05-29

SYNTHESIS OF PHOSPHATE DERIVATIVES

#9
20250034197
2025-01-30

NUCLEOSIDE-DIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY

#10
20250002989
2025-01-02

LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING

#11
20240391944
2024-11-28

ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#12
20240383940
2024-11-21

SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION

#13
20240368207
2024-11-07

COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS

#14
20240366649
2024-11-07

4-ETHYNYL-3-HYDROXY-TETRAHYDROFURANYL-ADENINE PHOSPHORAMIDATES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

#15
20240352057
2024-10-24

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

#16
20240336647
2024-10-10

NUCLEOSIDE ANALOGS AND THERAPEUTIC USE THEREOF

#17
20240294977
2024-09-05

FRET-LABELED COMPOUNDS AND USES THEREFOR

#18
20240285665
2024-08-29

Inhibitors of adenosine 5′-nucleotidase

#19
20240226130
2024-07-11

4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE

#20
20240209017
2024-06-27

Sting modulator compounds, and methods of making and using

#21
20240158640
2024-05-16

PROTECTED DYE-LABELED REAGENTS

#22
20240092819
2024-03-21

NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR

#23
20240091249
2024-03-21

METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)

#24
20240052410
2024-02-15

Modified nucleotide reagents

#25
20240024347
2024-01-25

PRODRUGS OF 6-MERCAPTOPURINE

#26
20240002426
2024-01-04

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

#27
20230399355
2023-12-14

Antimicrobial compounds, compositions, and uses thereof

#28
20230366018
2023-11-16

Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing

#29
20230340009
2023-10-26

Compounds for RNA capping and uses thereof

#30
20230287034
2023-09-14

CYCLIC DINUCLEOTIDES AS STING AGONISTS

#31
20230257413
2023-08-17

ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF

#32
20230212213
2023-07-06

A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT

#33
20230192750
2023-06-22

SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER COMPOUNDS

#34
20230183286
2023-06-15

NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA

#35
20230167151
2023-06-01

Substituted nucleosides, nucleotides and analogs thereof

#36
20230130333
2023-04-27

METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS

#37
20230026056
2023-01-26

Antimicrobial compounds, compositions, and uses thereof

#38
20220402962
2022-12-22

Synthesis of phosphate derivatives

#39
20220396702
2022-12-15

Protected dye-labeled reagents

#40
20220275019
2022-09-01

HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION

#41
20220267366
2022-08-25

BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT

#42
20220251637
2022-08-11

FRET-labeled compounds and uses therefor

#43
20220177510
2022-06-09

DERIVATIVES OF GYLCERO-MANNO-HEPTOSE ADP FOR USE IN MODULATING IMMUNE RESPONSE

#44
20220162253
2022-05-26

CD73 inhibitor, preparation method therefor and application thereof

#45
20220160746
2022-05-26

3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator

#46
20220127301
2022-04-28

ASYMMETRIC AUXILIARY GROUP

#47
20220119439
2022-04-21

5'-Cyclo-Phosphonate Modified Nucleotides

#48
20220054522
2022-02-24

Methods for the use of 5′-adenosine diphosphate ribose (ADPR)

#49
20210380628
2021-12-09

6-mercaptopurine nucleoside analogues

#50
20210371449
2021-12-02

Modulators of 5′-nucleotidase, ecto and the use thereof

#51
20210338706
2021-11-04

ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK

#52
20210277046
2021-09-09

Cyclic dinucleotides as sting agonists

#53
20210206797
2021-07-08

Method of solid-phase nucleic acid synthesis and solution composition for solid-phase nucleic acid synthesis

#54
20210206787
2021-07-08

Prodrugs of glutamine analogs

#55
20210205347
2021-07-08

Compounds, compositions, and methods for the treatment of disease

#56
20210179656
2021-06-17

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#57
20210171995
2021-06-10

Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor

#58
20210171566
2021-06-10

Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds

#59
20210171565
2021-06-10

Sting modulator compounds, and methods of making and using

#60
20210147928
2021-05-20

Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing

#61
20210147466
2021-05-20

IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF

#62
20210139959
2021-05-13

MODIFIED NUCLEOTIDE TRIPHOSPHATES FOR MOLECULAR ELECTRONIC SENSORS

#63
20210139523
2021-05-13

Substituted nucleosides, nucleotides and analogs thereof

#64
20210130387
2021-05-06

PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS

#65
20210009628
2021-01-14

Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT

#66
20210002322
2021-01-07

Modulators of 5′-nucleotidase, ecto and the use thereof

#67
20200385420
2020-12-10

Asymmetric auxiliary group

#68
20200331956
2020-10-22

β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n-substituted purine nucleotides for HCV treatment

#69
20200331955
2020-10-22

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment

#70
20200330498
2020-10-22

Methods for the use of 5'-adenosine diphosphate ribose (ADPR)

#71
20200318178
2020-10-08

FRET-labeled compounds and uses therefor

#72
20200308215
2020-10-01

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

#73
20200299319
2020-09-24

Protected dye-labeled reagents

#74
20200222441
2020-07-16

Inhibitors of adenosine 5′-nucleotidase

#75
20200190132
2020-06-18

3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA

#76
20200181190
2020-06-11

Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-738)

#77
20200181186
2020-06-11

Synthesis of phosphate derivatives

#78
20200157138
2020-05-21

NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES

#79
20200123192
2020-04-23

Compounds and methods used in assessing mono-PARP activity

#80
20200095273
2020-03-26

NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY

#81
20200087722
2020-03-19

Modified nucleotide reagents

#82
20200079813
2020-03-12

Substituted nucleosides, nucleotides and analogs thereof

#83
20200055891
2020-02-20

Phosphotriazole MRNA 5′-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide

#84
20200040026
2020-02-06

Trinucleotide mRNA cap analogs

#85
20200024297
2020-01-23

Substituted nucleosides, nucleotides and analogs thereof

#86
20190381081
2019-12-19

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#87
20190375780
2019-12-12

Malonyl-coenzyme A mimics as fatty acid synthase inhibitors and methods of use

#88
20190375779
2019-12-12

Phosphoramidate nucleoside derivatives as anticancer agents

#89
20190375774
2019-12-12

Compositions and methods for phosphoramidite and oligonucleotide synthesis

#90
20190336887
2019-11-07

Process for purifying NADPH

#91
20190315795
2019-10-17

Crystalline 3′,5′-cyclic diguanylic acid

#92
20190315784
2019-10-17

Prodrugs of glutamine analogs

#93
20190315783
2019-10-17

Prodrugs of glutamine analogs

#94
20190309010
2019-10-10

Modulators of 5′-nucleotidase, ecto and the use thereof

#95
20190271014
2019-09-05

Materials and Methods for Producing 6-Carbon Monomers

#96
20190225644
2019-07-25

MRNA CAP ANALOGS AND METHODS OF MRNA CAPPING

#97
20190177357
2019-06-13

Asymmetric auxiliary group

#98
20190177356
2019-06-13

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment

#99
20190135852
2019-05-09

Method for liquid-phase synthesis of nucleic acid

#100
20190100553
2019-04-04

DIRECT ACTIVITY ASSAYS AND COMPOSITIONS FOR NUCLEOTIDE POOL SANITIZING ENZYMES

#101
20190085012
2019-03-21

5′-cyclo-phosphonate modified nucleotides

#102
20190085011
2019-03-21

Substituted nucleosides, nucleotides and analogs thereof

#103
20190078127
2019-03-14

Method for using electrochemical bioreactor module with recovery of cofactor

#104
20190032117
2019-01-31

Fret-labeled compounds and uses therefor

#105
20190031703
2019-01-31

Substituted nucleosides, nucleotides and analogs thereof

#106
20190030057
2019-01-31

Cyclic dinucleotides as anticancer agents

#107
20180339055
2018-11-29

BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME

#108
20180282364
2018-10-04

Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

#109
20180258131
2018-09-13

NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY

#110
20180222930
2018-08-09

Prodrugs of glutamine analogs

#111
20180186828
2018-07-05

Cyclic di-nucleotides as modulators of STING

#112
20180162898
2018-06-14

4′-or nucleosides for the treatment of HCV

#113
20180162895
2018-06-14

Method for preparing nicotinamide mononucleotide (NMN)

#114
20180105551
2018-04-19

Trinucleotide MRNA cap analogs

#115
20180044369
2018-02-15

Substituted nucleosides, nucleotides and analogs thereof

#116
20180030082
2018-02-01

β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment

#117
20180030081
2018-02-01

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment

#118
20180009836
2018-01-11

β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections

#119
20180002368
2018-01-04

3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA

#120
20170321268
2017-11-09

Modified nucleotide reagents

#121
20170267710
2017-09-21

Modulators of 5′-nucleotidase, ecto and the use thereof

#122
20170176436
2017-06-22

METHODS (AMACR)

#123
20170166603
2017-06-15

LARGE STOKES SHIFT DYES

#124
20170159112
2017-06-08

AMPLIFIED ISOTHERMAL DETECTION OF POLYNUCLEOTIDES WITH ATP RELEASE

#125
20170146517
2017-05-25

COMPOUNDS AND METHODS USED IN ASSESSING MONO-PARP ACTIVITY

#126
20170145496
2017-05-25

Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing

#127
20170145495
2017-05-25

Protected dye-labeled reagents

#128
20170114085
2017-04-27

Chemical regeneration method of oxidized coenzyme NAD (P)+

#129
20170101432
2017-04-13

CRYSTALLINE 3',5'-CYCLIC DIGUANYLIC ACID

#130
20170037078
2017-02-09

2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER

#131
20170037077
2017-02-09

Substituted nucleosides, nucleotides and analogs thereof

#132
20170037075
2017-02-09

Substituted nucleosides, nucleotides and analogs thereof

#133
20170029456
2017-02-02

Nucleotides for the treatment of liver cancer

#134
20170029445
2017-02-02

Asymmetric auxiliary group

#135
20160360754
2016-12-15

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#136
20160340381
2016-11-24

Method for purifying reduced form of β-nicotinamide adenine dinucleotide

#137
20160340378
2016-11-24

METHOD FOR PURIFYING OXIDIZED FORM OF BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE

#138
20160331770
2016-11-17

Substituted nucleosides, nucleotides and analogs thereof

#139
20160281095
2016-09-29

Alkynyl-derivatized cap analogs, preparation and uses thereof

#140
20160271162
2016-09-22

D-ALANINE PHOSPHORAMIDE PRONUCLEOTIDES OF 2'-METHYL 2'-FLURO GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF HCV

#141
20160264611
2016-09-15

4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication

#142
20160257706
2016-09-08

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment

#143
20160222425
2016-08-04

Materials and methods for producing 6-carbon monomers

#144
20160201097
2016-07-14

Materials and Methods of Producing 7-Carbon Monomers

#145
20160130647
2016-05-12

Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing

#146
20160115186
2016-04-28

PHOSPHORIC ACID/PHOSPHONIC ACID DERIVATIVES AND MEDICINAL USES THEREOF

#147
20160095932
2016-04-07

Bone targeted therapeutics and methods of making and using the same

#148
20160090398
2016-03-31

Compounds useful for FRET and methods related thereto

#149
20160075732
2016-03-17

RADICAL ORBITAL SWITCHING

#150
20160068902
2016-03-10

SEQUENCING NUCLEIC ACIDS BY ENZYME ACTIVATION

#151
20160046661
2016-02-18

Ras inhibitors and uses thereof

#152
20160039861
2016-02-11

Substituted nucleosides, nucleotides and analogs thereof

#153
20160036061
2016-02-04

Tethering of confactors on graphene-like materials

#154
20160016987
2016-01-21

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#155
20150327547
2015-11-19

N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#156
20150315229
2015-11-05

Method for liquid-phase synthesis of nucleic acid

#157
20150315228
2015-11-05

Substituted nucleosides, nucleotides and analogs thereof

#158
20150315226
2015-11-05

Disulfide masked prodrug compositions and methods

#159
20150252373
2015-09-10

Alkynyl-derivatized cap analogs, preparation and uses thereof

#160
20150225758
2015-08-13

GENETICALLY MODIFIED CELLS AND METHODS FOR MAKING ACTIVATED SUGAR-NUCLEOTIDES

#161
20150225441
2015-08-13

4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication

#162
20150141363
2015-05-21

Substituted nucleotide analogs

#163
20150105341
2015-04-16

Substituted nucleosides, nucleotides and analogs thereof

#164
20150090936
2015-04-02

Large stokes shift dyes

#165
20150076062
2015-03-19

Hydrogel-based decontamination of aqueous samples containing nanoparticles

#166
20150051167
2015-02-19

Substituted nucleosides, nucleotides and analogs thereof

#167
20150018300
2015-01-15

2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections

#168
20140256930
2014-09-11

Enzyme function modification method and enzyme variant thereof

#169
20140248242
2014-09-04

Thiophosphate nucleosides for the treatment of HCV

#170
20140248241
2014-09-04

3′-deoxy nucleosides for the treatment of HCV

#171
20140235565
2014-08-21

-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents

#172
20140206640
2014-07-24

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#173
20140179910
2014-06-26

Substituted nucleosides, nucleotides and analogs thereof

#174
20140179627
2014-06-26

Substituted nucleosides, nucleotides and analogs thereof

#175
20140170711
2014-06-19

Nucleotide analogs and process for making same enzyme

#176
20140161770
2014-06-12

2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases

#177
20140155345
2014-06-05

Biotinylated compounds

#178
20140155336
2014-06-05

Water-soluble camptothecin derivative, pharmaceutical composition and use thereof

#179
20140154211
2014-06-05

2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#180
20140142291
2014-05-22

ENZYMATIC SYNTHESIS OF CARBA-NAD

#181
20140121108
2014-05-01

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#182
20140112887
2014-04-24

2′,4′-bridged nucleosides for HCV infection

#183
20140112886
2014-04-24

DINUCLEOTIDE COMPOUNDS FOR HCV INFECTION

#184
20140107060
2014-04-17

Fused pentacyclic polyethers

#185
20140106451
2014-04-17

Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom

#186
20140051625
2014-02-20

Bone targeted therapeutics and methods of making and using the same

#187
20130315864
2013-11-28

Macrocyclic nucleoside phosphoramidate derivatives

#188
20130237492
2013-09-12

Use of 2′,5′-oligoadenylate derivative compounds

#189
20130210757
2013-08-15

Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs

#190
20130165400
2013-06-27

Substituted nucleosides, nucleotides and analogs thereof

#191
20130164261
2013-06-27

Substituted nucleotide analogs

#192
20130108605
2013-05-02

METHOD OF AMELIORATING OXIDATIVE STRESS AND SUPPLEMENTING THE DIET

#193
20130102655
2013-04-25

Alkynyl-derivatized cap analogs, preparation and uses thereof

#194
20130071849
2013-03-21

Method for detecting reactants using fluorescent signal intensity

#195
20130064794
2013-03-14

Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections

#196
20130064793
2013-03-14

Compounds and pharmaceutical compositions for the treatment of viral infections

#197
20130018011
2013-01-17

METHOD OF TREATING DENGUE FEVER

#198
20120321550
2012-12-20

Mononuclear metal complex, hydrogenation reduction catalyst, dehydrogenation catalyst, method for producing hydrogenation reduction product, method for producing hydrogen (H), and method for producing dehydrogenation reaction product

#199
20120165515
2012-06-28

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

#200
20120142626
2012-06-07

2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections

#201
20120135951
2012-05-31

3′-azido purine nucleotide prodrugs for treatment of viral infections

#202
20120130062
2012-05-24

Enzymatic synthesis of carba-NAD

#203
20120122810
2012-05-17

Fused pentacyclic polyethers

#204
20120108533
2012-05-03

NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS

#205
20120052046
2012-03-01

Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

#206
20110313129
2011-12-22

LARGE STOKES SHIFT DYES

#207
20110306138
2011-12-15

Complex and method for enhancing nuclear delivery

#208
20110288286
2011-11-24

PROCESS FOR THE ENZYMATIC PRODUCTION OF CYCLIC DIGUANOSINE MONOPHOSPHATE EMPLOYING A DIGUANYLATE CYCLASE COMPRISING A MUTATED RXXD MOTIF

#209
20110257121
2011-10-20

Purine nucleoside phosphoramidate

#210
20110245484
2011-10-06

Stereoselective synthesis of phosphorus containing actives

#211
20110237525
2011-09-29

Method of ameliorating oxidative stress and supplementing the diet

#212
20110189671
2011-08-04

Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid

#213
20110165652
2011-07-07

COMPOSITIONS, METHODS AND SYSTEMS FOR SINGLE MOLECULE SEQUENCING

#214
20110081688
2011-04-07

Water-soluble rhodamine dyes conjugates

#215
20110014216
2011-01-20

Drug Transfer Based on Coenzyme A and Acyl Carrier Protein

#216
20100280234
2010-11-04

Photocleavable Protecting Groups and Methods for Their Use

#217
20100255488
2010-10-07

FRET-labeled compounds and uses therefor

#218
20100233757
2010-09-16

Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap

#219
20100227327
2010-09-09

METHODS AND COMPOSITIONS FOR CONTINUOUS SINGLE-MOLECULE NUCLEIC ACID SEQUENCING BY SYNTHESIS WITH FLUOROGENIC NUCLEOTIDES

#220
20100129820
2010-05-27

Strongly quenching oligomeric excimer/quencher pairs for detection schemes

#221
20100099643
2010-04-22

Fused Pentacyclic Polyethers

#222
20100048502
2010-02-25

BHQ-caged nucleotide probes photolysable by two-photon excitation

#223
20100044230
2010-02-25

Methods for separating carbon nanotubes

#224
20100036110
2010-02-11

METHODS AND COMPOSITIONS FOR CONTINUOUS SINGLE-MOLECULE NUCLEIC ACID SEQUENCING BY SYNTHESIS WITH FLUOROGENIC NUCLEOTIDES

#225
20090306007
2009-12-10

Nucleosides with antiviral and anticancer activity

#226
20090305433
2009-12-10

Water-soluble rhodamine dye conjugates

#227
20090286247
2009-11-19

Novel nucleic acid base pair

#228
20090258348
2009-10-15

ESTERASES FOR MONITORING PROTEIN BIOSYNTHESIS IN VITRO

#229
20090227544
2009-09-10

Bone targeted therapeutics and methods of making and using the same

#230
20080287671
2008-11-20

Drug-eluting stents coated with P2Yreceptor antagonist compound

#231
20080182815
2008-07-31

Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents

#232
20080026380
2008-01-31

Nucleotide analogs

#233
20070255045
2007-11-01

Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging

#234
20070179116
2007-08-02

Fused pentacyclic polyethers

#235
20070178487
2007-08-02

Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and “unnatural” UDP- and TDP-nucleotide sugars

#236
20060122143
2006-06-08

Drug-eluting stents coated with P2Yreceptor antagonist compound

#237
20050288240
2005-12-29

Prodrugs for phosphorus-containing compounds

#238
20050266148
2005-12-01

Photocleavable protecting groups and methods for their use

#239
20050191689
2005-09-01

Nucleic acid base pair

#240
20050153355
2005-07-14

Water-soluble rhodamine dye conjugates

#241
20050148539
2005-07-07

Fused pentacyclic polyethers

#242
20050130931
2005-06-16

Compositions for the treatment of glaucoma or ocular hypertension

#243
20050026864
2005-02-03

Bisphosphonate conjugates and methods of making and using the same

#244
20050009778
2005-01-13

Method for treating retinal degeneration with purinergic receptor agonists